Valora Therapeutics raises $30 million seed financing
Valora Therapeutics Inc., a biotechnology company specializing in immunotherapy, has successfully closed its seed funding round. The investment was co-led by Avalon BioVentures, Bregua Corporation, and TigerGene, with additional support from Alexandria Venture Investments and Correlation Ventures. The funds will…